"While following a zero tolerance policy for any laxity, the government will more than double the number of regulators in three years and set up state-of-the art testing labs at ports to ensure the pharmaceuticals and drugs exports shipments meet global quality standards," Drugs Controller General (India) G N Singh told reporters.
Singh was speaking after inauguration of the three-day international exhibition of pharma and health care - iPHEX 2014, here.
He said the central government will be spending over Rs 3,000 crore in the next three years (under the 12th Plan) towards enhancing the capacity of the regulators both at the Centre and state levels.
The number of regulators will increase to 1,000 from 500 at the Central level, while as many as 3,000 regulators will be deployed at the state levels, he said adding that in India, the regulatory system works at the dual level - at the Central and state levels.
"India's reference system for drugs testing and IP will be at par with the top world standards in two-three years and will even match the US in three-five years," Singh said.
India's regulators including DCGI himself along with state level FDAs have all gathered here at the 'iPHEX', organised by the industry body Pharmexcil and are engaged in deliberations with regulators from 40 countries.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
